#AI POC for demand forecasting

[jhnneelam]

Blood Urea Nitrogen Diagnostics Market Regional Growth, Trends Report 2037

The global Blood Urea Nitrogen (BUN) Diagnostics Market was valued at USD 1.3 billion in 2024 and is projected to grow steadily, reaching approximately USD 2.7 billion by 2034. This reflects a compound annual growth rate (CAGR) of 7% during the forecast period of 2025 to 2034. This growth is primarily driven by the increasing global incidence of kidney and liver disorders, aging populations, and the rising need for regular diagnostic monitoring among chronic disease patients.

Blood Urea Nitrogen Diagnostics Industry Demand

The Blood Urea Nitrogen (BUN) Diagnostics Market revolves around the detection and monitoring of urea nitrogen levels in the blood, a key marker for kidney and liver function. BUN testing plays a critical role in identifying disorders such as chronic kidney disease (CKD), liver dysfunction, and dehydration, among others. These tests are widely utilized due to their cost-effectiveness, ease of administration, and long shelf life, making them accessible in both clinical and remote settings.

The increasing awareness of preventive healthcare and the need for early diagnosis of renal complications are intensifying demand. Additionally, advancements in point-of-care testing and integration of BUN diagnostics into routine metabolic panels have expanded their utility, especially in emergency care settings and home healthcare monitoring.

 Blood Urea Nitrogen Diagnostics Market: Growth Drivers & Key Restraint

Growth Drivers –

Rising Prevalence of Chronic Diseases: The increasing global burden of chronic kidney disease, liver ailments, and diabetes has driven demand for routine BUN diagnostics. These tests are often the first line of investigation in assessing renal function, making them indispensable in chronic disease management.

Technological Advancements and Automation: Integration of automated analyzers, portable diagnostic kits, and AI-enhanced lab equipment has improved the speed, accuracy, and accessibility of BUN testing, especially in resource-limited settings and for home care use.

Outsourcing and Decentralized Testing Trends: The growing trend of diagnostic services being outsourced to third-party labs and the rise of decentralized diagnostics (home test kits and POC devices) have expanded the market reach of BUN diagnostics, especially in rural and underserved regions.

Restraint –

Limited Awareness and Infrastructure in Developing Countries: Despite the rising need, several developing nations still face challenges in terms of healthcare infrastructure, public awareness, and affordability of regular diagnostic tests, which may hinder market growth in certain regions.

Request Sample@ https://www.researchnester.com/sample-request-4147

 Blood Urea Nitrogen Diagnostics Market: Segment Analysis

Segment Analysis by Test Type –

Quantitative Tests: These are the most commonly adopted BUN diagnostic tests due to their precision in determining exact urea nitrogen levels. They are preferred in hospitals and laboratories for detailed metabolic analysis and chronic disease monitoring.

Semi-Quantitative Tests: Typically used in settings that require rapid yet fairly reliable diagnostics. Semi-quantitative formats are growing in popularity due to the rise in POC testing, especially in emergency and home care environments.

Qualitative Tests: These tests provide a simple positive/negative result and are generally used for initial screenings or in low-resource settings. They are beneficial for their quick turnaround and minimal equipment requirement, though they lack the precision of quantitative methods.

Segment Analysis by Application –

Chronic Kidney Disease (CKD): CKD remains the leading application area for BUN testing. Regular monitoring of blood urea levels is critical in managing disease progression, particularly in patients undergoing dialysis or conservative therapy.

Liver Dysfunction: Liver-related disorders often impact protein metabolism, leading to altered urea levels. BUN testing is an important adjunct in hepatic function assessments.

Gastrointestinal Bleeding and Dehydration: These conditions can result in elevated BUN levels, making diagnostics crucial in emergency settings. The use of BUN tests in triage and acute care continues to grow.

Dialysis Monitoring: Monitoring pre- and post-dialysis BUN levels helps assess the efficacy of dialysis treatment. With increasing dialysis cases worldwide, this application is gaining importance.

Emergency Care: In emergency departments, BUN testing aids rapid evaluation of renal function, guiding urgent clinical decisions. The demand in this segment is expanding due to the need for swift diagnostics.

Segment Analysis by End‑User –

Hospitals & Clinics: These facilities remain the largest consumers of BUN diagnostics due to the availability of lab infrastructure and trained personnel. The demand is driven by routine metabolic testing and emergency diagnostics.

Diagnostic Laboratories: With the rise of outsourced testing and centralized lab services, diagnostic labs are witnessing increasing adoption of advanced BUN diagnostic technologies.

Home Healthcare Settings: A fast-growing segment, home testing for BUN is becoming increasingly feasible with user-friendly POC devices and self-monitoring kits. Aging populations and chronic disease patients are the primary users.

Research & Academic Institutes: These institutions use BUN diagnostics for experimental and longitudinal studies on renal and hepatic function, contributing to market innovation and clinical guidelines.

 Blood Urea Nitrogen Diagnostics Market: Regional Insights

North America

North America leads the BUN Diagnostics Market owing to its well-established healthcare system, high prevalence of chronic kidney disease, and strong adoption of advanced diagnostic technologies. Government-led initiatives supporting chronic disease management and widespread health insurance coverage further stimulate market growth.

Europe

Europe follows closely, driven by rising geriatric populations and increasing focus on preventive healthcare. Countries such as Germany, France, and the UK are prioritizing early detection of kidney diseases through routine blood tests, boosting the uptake of BUN diagnostics across public and private sectors.

Asia-Pacific (APAC)

APAC is emerging as the fastest-growing region due to improving healthcare access, rising awareness of kidney health, and government investments in rural healthcare infrastructure. Countries like China and India present vast market potential given their large populations and growing burden of lifestyle-related illnesses.

Top Players in the Blood Urea Nitrogen Diagnostics Market

The Blood Urea Nitrogen Diagnostics Market is competitive and characterized by both multinational corporations and regional players. Key companies include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Beckman Coulter, Thermo Fisher Scientific, Sysmex Corporation, Mindray Medical, Ortho Clinical Diagnostics, Randox Laboratories, Fujifilm Wako Pure Chemical, Bio-Rad Laboratories, Tosoh Corporation, Transasia Bio-Medicals, Seegene Inc., Horiba Medical, Biotecnica Instruments, Nova Biomedical, SD Biosensor, Beacon Diagnostics, and Mediven Sdn. Bhd. These companies focus on innovation, strategic partnerships, and expanding product portfolios to maintain a competitive edge in a growing diagnostics landscape.

Access Detailed Report@ https://www.researchnester.com/reports/blood-urea-nitrogen-diagnostics-market/4147  

Contact for more Info:

AJ Daniel

Email: info@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

[health-views-updates]

How Is the Aging Population Affecting the IVD (In Vitro Diagnostics) Market?

The IVD (In Vitro Diagnostics) Market is poised for steady growth, having reached a value of USD 83.04 billion in 2023, and is projected to surge to USD 126.6 billion by 2032, growing at a CAGR of 4.8% over the forecast period from 2024 to 2032. This growth is largely attributed to increasing healthcare demands, a rising elderly population, and innovations in diagnostic technology. For more information on the projected figures and market dynamics, visit the detailed report on IVD (In Vitro Diagnostics) Market Size.

As diagnostic procedures evolve, healthcare systems globally are placing more emphasis on early and accurate disease detection. The IVD market encompasses instruments, reagents, and software used to perform diagnostic tests on samples taken from the human body. These tests are critical in detecting infectious diseases, cancer, cardiovascular conditions, and various genetic disorders.

Market Drivers and Opportunities

Key drivers of the IVD market include the increase in chronic and infectious diseases, expanding use of point-of-care (PoC) testing, and a growing preference for personalized medicine. The COVID-19 pandemic has further elevated the importance of rapid diagnostic tools, which has had a lasting impact on market dynamics.

Moreover, technological advancements such as automation, AI integration, and next-generation sequencing (NGS) are reshaping the way diagnostic services are delivered. Regulatory support, particularly in the U.S. and Europe, has also played a vital role in accelerating the development and approval of advanced IVD devices.

Regional Insights

North America holds the largest market share, fueled by established healthcare infrastructure, high awareness levels, and the presence of key market players. However, the Asia-Pacific region is expected to exhibit the highest growth rate due to increasing healthcare expenditures, supportive government initiatives, and a rapidly expanding population base.

Emerging markets in Latin America, the Middle East, and Africa are also showing significant potential, offering untapped opportunities for both local and global manufacturers to expand their footprint.

Competitive Landscape

The IVD market is highly competitive and fragmented, featuring leading players such as Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Danaher Corporation, and Thermo Fisher Scientific. These companies are investing heavily in research and development to expand their product portfolios, enhance diagnostic accuracy, and meet growing global demand.

Mergers, acquisitions, and strategic partnerships are becoming increasingly common as companies aim to strengthen their market position and capitalize on technological innovations.

Challenges Ahead

Despite its growth, the IVD market faces challenges including regulatory hurdles, reimbursement issues, and data privacy concerns related to digital diagnostics. Additionally, high equipment costs and limited accessibility in low-income regions may restrain market penetration.

Looking Ahead

With healthcare ecosystems shifting toward preventive care and personalized treatment, the IVD market is expected to maintain its upward trajectory. Players who can innovate while keeping regulatory and cost-effectiveness aspects in balance will be well-positioned for success.

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us: Jagney Dave – Vice President of Client Engagement 📞 Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) 📧 Email: info@snsinsider.com

Other Trending Reports

Intravenous Immunoglobulin Market

Urology Devices Market

Occupational Health Market

Calcium Supplements Market

[sanikavijaymane]

Portable Ultrasound Market by Product (POCUS, Handheld

Ultrasound, Transducer, Gels), Technology (2D, 3D, 4D, Doppler),

Display, Application (Breast Cancer, MSK, OB/GYN, CVD, Urology),

End User (Hospitals, ACC, Imaging Center) – Global Forecast to 2031

Meticulous Research

®

—a leading global market research company, published a research report titled, ‘Portable Ultrasound Market By Product (POCUS,

Handheld Ultrasound, Transducer, Gels), Technology (2D, 3D, 4D, Doppler), Display, Application (Breast Cancer, MSK, OB/GYN, CVD, Urology), End User

(Hospitals, ACC, Imaging Center) – Global Forecast to 2031.’

According to this latest publication from Meticulous Research®, the global Portable Ultrasound Market is projected to reach $3.8 billion by 2031, at a CAGR of 7.9% during

the forecast period 2024–2031. The growth of the portable ultrasound market is driven by factors such as the growing adoption of portable medical devices in emergency

care settings, the proliferation of hospitals, and the increasing demand for handheld ultrasound devices in ambulatory care centers and dialysis centers.

The growing preference for portable ultrasound devices over standard ultrasound machines among healthcare professionals and the rising demand from emerging economies

are expected to create growth opportunities for players operating in this market. However, factors such as the shortage of skilled professionals, inadequate training programs

for healthcare professionals on the use of portable ultrasound devices, reimbursement irregularities, poor image quality, and integration issues of portable ultrasound devices

with existing digital health infrastructure pose challenges to the market's growth.

Key Players

The key players operating in global Portable Ultrasound Market are GE Healthcare Technologies Inc. (U.S.), Siemens Healthineers AG (Germany), Shenzhen Mindray Bio-

Medical Electronics Co., Ltd. (China), Koninklijke Philips N.V., (Netherlands), Samsung Medison Co. Ltd. (A subsidiary of Samsung Electronics Co. Ltd.) (South Korea),

FUJIFILM Sonosite, Inc. (A subsidiary of FUJIFILM Holdings Corporation) (U.S.), ALPINION MEDICAL SYSTEMS Co., Ltd. (South Korea), Esaote S.p.A (Italy),

EDAN Instruments, Inc. (China), EchoNous, Inc. (U.S.), Butterfly Network, Inc. (U.S.), Konica Minolta, Inc. (Japan), CHISON Medical Technologies Co., Ltd (China),

SonoScape Medical Corp. (China), and Healcerion Co., Ltd. (South Korea).

Portable Ultrasound Market: Future Outlook

The global Portable Ultrasound Market is segmented by product (Devices [by Portability {Point-of-care (PoC) Ultrasound (Machines and Transducers), Handheld

Ultrasound}, by Technology {2D, 3D & 4D, Doppler}, by Display {Black & White (B/W), Colored}], Gels, Accessories), Application ( OB/GYN, Cardiovascular, Urology,

Musculoskeletal, Breast Cancer, Other Applications), End User (Hospitals & Clinics, Diagnostic Imaging Centers, Ambulatory Care Centers, Other End Users) and

Geography. The study also evaluates industry competitors and analyzes the market at regional and country levels.

Based on product, the global portable ultrasound market is segmented into devices, gels, and accessories. In 2024, the devices segment is expected to account for the largest

share of the market. The large market share of this segment is attributed to the growing demand for POCUS in emergency departments, increasing preference for ultrasound

imaging near patients, the growing prevalence of chronic diseases, and technological advancements in portable ultrasound devices.

Based on portability, the devices segment is further sub-segmented into point-of-care (PoC) ultrasound and handheld ultrasound. The handheld ultrasound segment is

expected to register a higher CAGR during the forecast period. This growth is attributed to the development and introduction of new handheld ultrasound devices tailored for

specific applications, integration of artificial intelligence (AI) and machine learning, and other technological advancements.

Based on application, the global portable ultrasound market is segmented into OB/GYN, cardiovascular, urology, musculoskeletal, breast cancer, and other applications. In

2024, the OB/GYN segment is expected to account for the largest share of the global portable ultrasound market. The large market share of this segment can be attributed to

the growing prevalence of conditions related to women’s reproductive health, reduction in global infertility rates, and high incidence & rising awareness regarding early

diagnosis and monitoring of PCOD & PCOS.

According to data published by the WHO in 2023, Polycystic ovarian syndrome (PCOS) is characterized by an ovary with a follicle count ≥12 and a size of 2 or 3 mm3. This

syndrome produces side effects related to women’s overall health, such as abnormal hair growth, weight gain, irregular menstrual cycle, infertility, and depression. Almost

70% of women with PCOS have infertility, and this condition is one of the common reasons for female infertility. PCOS occurs in women during their reproductive years,

between 18 and 45 years old.

Based on end user, the global portable ultrasound market is segmented into hospitals & clinics, diagnostic imaging centers, ambulatory care centers, and other end users. In

2024, the hospitals & clinics segment is expected to account for the largest share of the portable ultrasound market. The large market share of this segment is attributed to the

increasing hospitalizations due to chronic diseases associated with an aging population, increasing healthcare expenditure, the adoption of advanced imaging modalities in

hospitals, preference for low-cost products to control healthcare costs, rising focus on providing point-of-care/bedside service to patients, and the proliferation of healthcare

facilities especially in emerging economies.

Portable ultrasound systems, including POCUS and handheld ultrasound, can be used near patient areas and do not require patients to visit special medical imaging centers

for the diagnosis of various medical conditions. Moreover, getting a bedside medical imaging facility helps healthcare professionals in early diagnosis and treatment planning,

driving the adoption of portable ultrasound in hospitals and clinics.

Geographic Review

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain,

Switzerland, and the Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, Australia, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin

America), and Middle East & Africa. China is expected to register the highest CAGR during the forecast period (2024-2031). This growth can be attributed to the rising

incidence of orthopedic injuries and cancer, the aging demographic, government initiatives aimed at encouraging early disease detection, the widespread adoption of

advanced medical technologies, ongoing improvements in healthcare infrastructure, and increasing healthcare spending.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5800

Key questions answered in the report-



What is the current revenue generated by the portable ultrasound market across the globe?



At what rate is the demand for global portable ultrasound projected to grow for the next 5-7 years?Global Portable Ultrasound Market Market – 2016-2022

Page 2 of 3

© Meticulous Research| sales@meticulousresearch.com



What is the historical market size and growth rate for the portable ultrasound market across the globe?



What are the major factors impacting the growth of this market at the global and regional levels? What are the major opportunities for existing market players

and new entrants in the market?



Which segments are creating major traction for the vendors in this market in terms of product, application, and end user?



What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the vendors operating in

the global Portable Ultrasound Market?



Who are the major players in the global portable ultrasound market? And what are their specific products offered in the portable ultrasound industry?



What recent developments have taken place in the global portable ultrasound market, and how are these strategic developments impacting the market?

Contact Us:

Meticulous Research®

Email- sales@meticulousresearch.com

Contact Sales- +1-646-781-8004

Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

[appson]

AI Consulting Services: What They Are and Why Your Business Needs Them Now

In today’s fast-paced digital world, businesses must constantly evolve to stay competitive. One of the most transformative innovations in recent years is artificial intelligence (AI). From automating tasks to enhancing decision-making, AI has revolutionized how organizations operate. To implement AI effectively, many companies turn to AI Consulting Services for expert guidance and strategic integration.

What Are AI Consulting Services?

AI Consulting Services involve specialized expertise offered by professionals or firms who help businesses integrate artificial intelligence into their operations. These services typically include:

AI strategy development

AI model design and training

Data analysis and infrastructure

Custom AI solutions

Risk analysis and compliance

By leveraging these services, companies can identify AI use cases, assess feasibility, and develop tailored implementation plans that align with their business goals.

Why Businesses Need AI Consulting

The adoption of AI is no longer optional; it’s a necessity. Here are the key reasons why businesses must invest in AI Consulting today:

1. Strategic Guidance

AI is complex. Without proper direction, companies risk wasting resources on ineffective solutions. AI consultants provide strategic roadmaps to ensure AI initiatives align with business objectives.

2. Cost-Effective Implementation

Instead of building in-house AI capabilities from scratch, businesses can rely on consulting firms to deliver efficient, scalable solutions without the overhead.

3. Access to Expertise

AI consultants bring deep technical and industry-specific knowledge. Their experience helps companies avoid pitfalls and accelerate AI adoption.

4. Staying Competitive

Competitors are already using AI for marketing, customer service, logistics, and analytics. With AI consulting, businesses can match or surpass industry benchmarks.

What Do AI Consulting Firms Offer?

AI Consulting Firms provide a wide range of services, including:

Feasibility studies

Proof of concept (PoC) development

AI product lifecycle management

Integration with existing systems

Training and upskilling teams

Their comprehensive approach ensures your AI solution is not just functional but optimized for long-term success. Whether you're in healthcare, retail, finance, or manufacturing, there's an AI strategy to meet your unique needs.

Choosing the Right AI Consulting Agency

When selecting an AI Consulting Agency, consider the following factors:

Experience: Look for agencies with proven success stories in your industry.

Customization: The agency should offer tailored solutions, not one-size-fits-all templates.

Transparency: A good consulting partner explains the process, costs, and expected outcomes clearly.

Support: Post-implementation support is crucial to refine and scale your AI systems.

By choosing the right agency, businesses can mitigate risks and maximize ROI from their AI investments.

Real-World Applications of AI Consulting

AI consulting has enabled businesses to:

Automate customer support with chatbots

Predict customer behavior through advanced analytics

Enhance supply chain efficiency with demand forecasting

Detect fraud in real-time within financial transactions

These implementations lead to measurable improvements in performance, customer satisfaction, and cost savings.

Conclusion

AI is reshaping the future of every industry. Businesses that want to remain relevant must start integrating AI now. Engaging a professional AI Consulting Firm ensures that your journey into AI is strategic, cost-effective, and impactful. Whether you're optimizing operations or exploring new revenue streams, partnering with a trusted consultant can make all the difference.

Embrace the future with confidence. Let a reliable AI Consulting Agency guide your transformation. Visit https://appsontechnologies.com/ for more details.

Original Source: https://bit.ly/44wlvif

[mordormr]

Companion Animal Healthcare Market: A Growing Industry Driven by Pet Wellness Trends 

Introduction 

The companion animal healthcare market is projected to grow from USD 19.52 billion in 2025 to USD 30.07 billion by 2030, registering a compound annual growth rate (CAGR) of 9.03% during the forecast period. 

The Companion Animal Healthcare Market refers to the industry that provides medical services, pharmaceuticals, diagnostics, and preventive care for pets such as dogs, cats, and other domesticated animals. As pet ownership continues to rise globally, especially in urban areas, there is a growing demand for comprehensive health solutions that mirror human healthcare standards. 

This market is shaped by increasing awareness among pet owners about animal health, the growing trend of pet humanization, and the availability of advanced veterinary services. From routine vaccinations and parasite control to diagnostics, surgical procedures, and chronic disease management, the companion animal healthcare sector is becoming an essential part of modern pet care. As a result, it offers significant opportunities for pharmaceutical companies, veterinary clinics, diagnostics providers, and digital health platforms. 

Key Trends Shaping the Market 

Therapeutics Dominate, Diagnostics Expand Fast 

Therapeutics (vaccines, parasiticides, biologics) represent ~43–45% of market revenue 

Diagnostics (including POC analyzers) are growing fastest with ~12% CAGR  

Premium & Preventive Veterinary Services 

Veterinary hospital clinics still account for over 50% of distribution, though e‑commerce platforms are catching up (~10–11% CAGR)  

Telemedicine is rising, enabling remote consults and expanding coverage  

Subscription Wellness & Smart Technologies 

Integration of AI diagnostics, pet wearables, and data-driven wellness subscriptions is reshaping veterinary care  

Mental Health & Behavorial Monitoring 

Emerging focus on mental well-being is spurring development of anxiety treatments, stress-tracking wearables, and behavioural therapy products. 

Major Players 

Zoetis – Over US$ 9.3 billion in 2024 sales; strong foothold in parasiticides (Simparica Trio) and dermatology (Apoquel); facing competition from Merck’s Numelvi and Elanco’s Zenrelia. 

Merck Animal Health (Intervet) – A strong competitor, especially with upcoming approvals like Numelvi challenging Zoetis’s Apoquel 

Elanco – Third-largest animal-health firm, offers Zenrelia and CQ parasiticide in direct competition. 

IDEXX Laboratories – Leader in veterinary diagnostics; offers in-clinic analyzers and software systems (e.g., Catalyst Dx, Cornerstone) 

Other Big Names: Bayer, Boehringer Ingelheim, Ceva, Heska, Vetoquinol, Virbac  

For More information visit Companion Animal Healthcare Market Key players 

Challengers & Disruption 

Emerging Biotech & Startups – Companies like Basepaws and PetMedix (now under Zoetis) innovate in genetics and species-specific biologics. 

Digital Health & E-commerce Platforms – Telemedicine services (e.g., Fuzzy, PetDesk) and online pharmacies/channels are disrupting traditional clinic models. 

Price Pressure & Consolidation Scrutiny – Regulatory scrutiny in the US and UK is rising due to opaque pricing, medication mark-ups, and veterinary sector consolidation. This may limit pricing leverage among large veterinary groups. 

Competitive Landscape 

Consolidation Trends: Private equity-backed chains (e.g., IVC Evidensia, Vet Partners) now control ~60% of the UK vet market; similar consolidation seen in the US  

Competitive Pressure & Innovation: Zoetis leads, but Merck and Elanco are aggressively challenging in dermatology and parasiticides Diagnostics (IDEXX) are becoming essential parts of service offerings. 

Tech-Driven Business Models: Digital wellness plans, telehealth, POC diagnostics, and e‑commerce are blurring the lines between pharmaceuticals, hardware/software, and services—leading to differentiated strategies across key players. 

Challenges & Opportunities 

Cost vs Access: Advanced treatments are expensive, often necessitating pet insurance or premium pricing. 

Regulatory & Price Transparency: Increased scrutiny and calls for pricing caps may compress margins; stronger regulation ahead. 

Growth in Emerging Markets: APAC, especially India, offers high potential, supported by government initiatives and rising awareness  

One-Health Synergies: Data from veterinary visits (e.g., zoonotic surveillance) is increasingly valued by public health systems 

For a detailed overview and more insights, you can refer to the full market research report by Mordor Intelligence: https://www.mordorintelligence.com/industry-reports/companion-animal-healthcare-market?utm_source=tumblr 

    About Mordor Intelligence:  

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. 

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics. 

For any inquiries or to access the full report, please contact: 

media@mordorintelligence.com   https://www.mordorintelligence.com/ 

[rutkdm]

Portable Ultrasound Market Growth Forecast 2024 to 2031

Meticulous Research®—a leading global market research company, published a research report titled, ‘Portable Ultrasound Market By Product (POCUS, Handheld Ultrasound, Transducer, Gels), Technology (2D, 3D, 4D, Doppler), Display, Application (Breast Cancer, MSK, OB/GYN, CVD, Urology), End User (Hospitals, ACC, Imaging Center) – Global Forecast to 2031.’

According to this latest publication from Meticulous Research®, the global Portable Ultrasound Market is projected to reach $3.8 billion by 2031, at a CAGR of 7.9% during the forecast period 2024–2031. The growth of the portable ultrasound market is driven by factors such as the growing adoption of portable medical devices in emergency care settings, the proliferation of hospitals, and the increasing demand for handheld ultrasound devices in ambulatory care centers and dialysis centers.

The growing preference for portable ultrasound devices over standard ultrasound machines among healthcare professionals and the rising demand from emerging economies are expected to create growth opportunities for players operating in this market. However, factors such as the shortage of skilled professionals, inadequate training programs for healthcare professionals on the use of portable ultrasound devices, reimbursement irregularities, poor image quality, and integration issues of portable ultrasound devices with existing digital health infrastructure pose challenges to the market's growth.

Key Players

The key players operating in global Portable Ultrasound Market are GE Healthcare Technologies Inc. (U.S.), Siemens Healthineers AG (Germany), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Koninklijke Philips N.V., (Netherlands), Samsung Medison Co. Ltd. (A subsidiary of Samsung Electronics Co. Ltd.) (South Korea), FUJIFILM Sonosite, Inc. (A subsidiary of FUJIFILM Holdings Corporation) (U.S.), ALPINION MEDICAL SYSTEMS Co., Ltd. (South Korea), Esaote S.p.A (Italy), EDAN Instruments, Inc. (China), EchoNous, Inc. (U.S.), Butterfly Network, Inc. (U.S.), Konica Minolta, Inc. (Japan), CHISON Medical Technologies Co., Ltd (China), SonoScape Medical Corp. (China), and Healcerion Co., Ltd. (South Korea).

Portable Ultrasound Market: Future Outlook

The global Portable Ultrasound Market is segmented by product (Devices [by Portability {Point-of-care (PoC) Ultrasound (Machines and Transducers), Handheld Ultrasound}, by Technology {2D, 3D & 4D, Doppler}, by Display {Black & White (B/W), Colored}], Gels, Accessories), Application ( OB/GYN, Cardiovascular, Urology, Musculoskeletal, Breast Cancer, Other Applications), End User (Hospitals & Clinics, Diagnostic Imaging Centers, Ambulatory Care Centers, Other End Users) and Geography. The study also evaluates industry competitors and analyzes the market at regional and country levels.

Based on product, the global portable ultrasound market is segmented into devices, gels, and accessories. In 2024, the devices segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the growing demand for POCUS in emergency departments, increasing preference for ultrasound imaging near patients, the growing prevalence of chronic diseases, and technological advancements in portable ultrasound devices.

Based on portability, the devices segment is further sub-segmented into point-of-care (PoC) ultrasound and handheld ultrasound. The handheld ultrasound segment is expected to register a higher CAGR during the forecast period. This growth is attributed to the development and introduction of new handheld ultrasound devices tailored for specific applications, integration of artificial intelligence (AI) and machine learning, and other technological advancements.

Based on application, the global portable ultrasound market is segmented into OB/GYN, cardiovascular, urology, musculoskeletal, breast cancer, and other applications. In 2024, the OB/GYN segment is expected to account for the largest share of the global portable ultrasound market. The large market share of this segment can be attributed to the growing prevalence of conditions related to women’s reproductive health, reduction in global infertility rates, and high incidence & rising awareness regarding early diagnosis and monitoring of PCOD & PCOS.

According to data published by the WHO in 2023, Polycystic ovarian syndrome (PCOS) is characterized by an ovary with a follicle count ≥12 and a size of 2 or 3 mm3. This syndrome produces side effects related to women’s overall health, such as abnormal hair growth, weight gain, irregular menstrual cycle, infertility, and depression. Almost 70% of women with PCOS have infertility, and this condition is one of the common reasons for female infertility. PCOS occurs in women during their reproductive years, between 18 and 45 years old.

Based on end user, the global portable ultrasound market is segmented into hospitals & clinics, diagnostic imaging centers, ambulatory care centers, and other end users. In 2024, the hospitals & clinics segment is expected to account for the largest share of the portable ultrasound market. The large market share of this segment is attributed to the increasing hospitalizations due to chronic diseases associated with an aging population, increasing healthcare expenditure, the adoption of advanced imaging modalities in hospitals, preference for low-cost products to control healthcare costs, rising focus on providing point-of-care/bedside service to patients, and the proliferation of healthcare facilities especially in emerging economies.

Portable ultrasound systems, including POCUS and handheld ultrasound, can be used near patient areas and do not require patients to visit special medical imaging centers for the diagnosis of various medical conditions. Moreover, getting a bedside medical imaging facility helps healthcare professionals in early diagnosis and treatment planning, driving the adoption of portable ultrasound in hospitals and clinics.

Geographic Review

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, and the Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, Australia, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa. China is expected to register the highest CAGR during the forecast period (2024-2031). This growth can be attributed to the rising incidence of orthopedic injuries and cancer, the aging demographic, government initiatives aimed at encouraging early disease detection, the widespread adoption of advanced medical technologies, ongoing improvements in healthcare infrastructure, and increasing healthcare spending.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5800

Key questions answered in the report-

What is the current revenue generated by the portable ultrasound market across the globe?

At what rate is the demand for global portable ultrasound projected to grow for the next 5-7 years?

What is the historical market size and growth rate for the portable ultrasound market across the globe?

What are the major factors impacting the growth of this market at the global and regional levels? What are the major opportunities for existing market players and new entrants in the market?

Which segments are creating major traction for the vendors in this market in terms of product, application, and end user?

What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the global Portable Ultrasound Market?

Who are the major players in the global portable ultrasound market? And what are their specific products offered in the portable ultrasound industry?

What recent developments have taken place in the global portable ultrasound market, and how are these strategic developments impacting the market?

Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

[rutukadam]

Trends in Portable Ultrasound Technology and Applications

Meticulous Research®—a leading global market research company, published a research report titled, ‘Portable Ultrasound Market By Product (POCUS, Handheld Ultrasound, Transducer, Gels), Technology (2D, 3D, 4D, Doppler), Display, Application (Breast Cancer, MSK, OB/GYN, CVD, Urology), End User (Hospitals, ACC, Imaging Center) – Global Forecast to 2031.’

According to this latest publication from Meticulous Research®, the global Portable Ultrasound Market is projected to reach $3.8 billion by 2031, at a CAGR of 7.9% during the forecast period 2024–2031. The growth of the portable ultrasound market is driven by factors such as the growing adoption of portable medical devices in emergency care settings, the proliferation of hospitals, and the increasing demand for handheld ultrasound devices in ambulatory care centers and dialysis centers.

The growing preference for portable ultrasound devices over standard ultrasound machines among healthcare professionals and the rising demand from emerging economies are expected to create growth opportunities for players operating in this market. However, factors such as the shortage of skilled professionals, inadequate training programs for healthcare professionals on the use of portable ultrasound devices, reimbursement irregularities, poor image quality, and integration issues of portable ultrasound devices with existing digital health infrastructure pose challenges to the market's growth.

Key Players

The key players operating in global Portable Ultrasound Market are GE Healthcare Technologies Inc. (U.S.), Siemens Healthineers AG (Germany), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Koninklijke Philips N.V., (Netherlands), Samsung Medison Co. Ltd. (A subsidiary of Samsung Electronics Co. Ltd.) (South Korea), FUJIFILM Sonosite, Inc. (A subsidiary of FUJIFILM Holdings Corporation) (U.S.), ALPINION MEDICAL SYSTEMS Co., Ltd. (South Korea), Esaote S.p.A (Italy), EDAN Instruments, Inc. (China), EchoNous, Inc. (U.S.), Butterfly Network, Inc. (U.S.), Konica Minolta, Inc. (Japan), CHISON Medical Technologies Co., Ltd (China), SonoScape Medical Corp. (China), and Healcerion Co., Ltd. (South Korea).

Portable Ultrasound Market: Future Outlook

The global Portable Ultrasound Market is segmented by product (Devices [by Portability {Point-of-care (PoC) Ultrasound (Machines and Transducers), Handheld Ultrasound}, by Technology {2D, 3D & 4D, Doppler}, by Display {Black & White (B/W), Colored}], Gels, Accessories), Application ( OB/GYN, Cardiovascular, Urology, Musculoskeletal, Breast Cancer, Other Applications), End User (Hospitals & Clinics, Diagnostic Imaging Centers, Ambulatory Care Centers, Other End Users) and Geography. The study also evaluates industry competitors and analyzes the market at regional and country levels.

Based on product, the global portable ultrasound market is segmented into devices, gels, and accessories. In 2024, the devices segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the growing demand for POCUS in emergency departments, increasing preference for ultrasound imaging near patients, the growing prevalence of chronic diseases, and technological advancements in portable ultrasound devices.

Based on portability, the devices segment is further sub-segmented into point-of-care (PoC) ultrasound and handheld ultrasound. The handheld ultrasound segment is expected to register a higher CAGR during the forecast period. This growth is attributed to the development and introduction of new handheld ultrasound devices tailored for specific applications, integration of artificial intelligence (AI) and machine learning, and other technological advancements.

Based on application, the global portable ultrasound market is segmented into OB/GYN, cardiovascular, urology, musculoskeletal, breast cancer, and other applications. In 2024, the OB/GYN segment is expected to account for the largest share of the global portable ultrasound market. The large market share of this segment can be attributed to the growing prevalence of conditions related to women’s reproductive health, reduction in global infertility rates, and high incidence & rising awareness regarding early diagnosis and monitoring of PCOD & PCOS.

According to data published by the WHO in 2023, Polycystic ovarian syndrome (PCOS) is characterized by an ovary with a follicle count ≥12 and a size of 2 or 3 mm3. This syndrome produces side effects related to women’s overall health, such as abnormal hair growth, weight gain, irregular menstrual cycle, infertility, and depression. Almost 70% of women with PCOS have infertility, and this condition is one of the common reasons for female infertility. PCOS occurs in women during their reproductive years, between 18 and 45 years old.

Based on end user, the global portable ultrasound market is segmented into hospitals & clinics, diagnostic imaging centers, ambulatory care centers, and other end users. In 2024, the hospitals & clinics segment is expected to account for the largest share of the portable ultrasound market. The large market share of this segment is attributed to the increasing hospitalizations due to chronic diseases associated with an aging population, increasing healthcare expenditure, the adoption of advanced imaging modalities in hospitals, preference for low-cost products to control healthcare costs, rising focus on providing point-of-care/bedside service to patients, and the proliferation of healthcare facilities especially in emerging economies.

Portable ultrasound systems, including POCUS and handheld ultrasound, can be used near patient areas and do not require patients to visit special medical imaging centers for the diagnosis of various medical conditions. Moreover, getting a bedside medical imaging facility helps healthcare professionals in early diagnosis and treatment planning, driving the adoption of portable ultrasound in hospitals and clinics.

Geographic Review

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, and the Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, Australia, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa. China is expected to register the highest CAGR during the forecast period (2024-2031). This growth can be attributed to the rising incidence of orthopedic injuries and cancer, the aging demographic, government initiatives aimed at encouraging early disease detection, the widespread adoption of advanced medical technologies, ongoing improvements in healthcare infrastructure, and increasing healthcare spending.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5800

Key questions answered in the report-

What is the current revenue generated by the portable ultrasound market across the globe?

At what rate is the demand for global portable ultrasound projected to grow for the next 5-7 years?

What is the historical market size and growth rate for the portable ultrasound market across the globe?

What are the major factors impacting the growth of this market at the global and regional levels? What are the major opportunities for existing market players and new entrants in the market?

Which segments are creating major traction for the vendors in this market in terms of product, application, and end user?

What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the global Portable Ultrasound Market?

Who are the major players in the global portable ultrasound market? And what are their specific products offered in the portable ultrasound industry?

What recent developments have taken place in the global portable ultrasound market, and how are these strategic developments impacting the market?

Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

[mastergarryblogs]

Emerging Trends in the Global Allergy Diagnostics Market: What to Expect by 2030

Allergy Diagnostics Market Overview and Forecast Insights

The global allergy diagnostics market is entering a critical growth phase, projected to expand at a CAGR of 10.3% from 2024 to 2031. This surge is driven by increasing urbanization, worsening air quality, rising allergy incidence rates, and advancements in diagnostic technologies. Inhaled allergens currently dominate the market, and consumables remain the most demanded product segment, fueling consistent growth across key regions such as North America, Europe, and Asia-Pacific.

Request Sample Report PDF (including TOC, Graphs & Tables): https://www.statsandresearch.com/request-sample/40375-global-allergy-diagnostics-market

Inhaled Allergens Lead Market Demand

Segment Analysis: By Allergen

Inhaled allergens account for the largest and fastest-growing share of the market due to intensifying air pollution levels in urban centers. Substances such as dust mites, pollen, mold spores, and pet dander have seen heightened sensitization rates among global populations. According to clinical trends, allergic rhinitis and asthma diagnoses are sharply rising, further boosting demand for diagnostic kits focused on airborne allergens.

Key Allergy Diagnostics Market Drivers:

Escalating air quality issues in industrialized and urban zones

Indoor pollution from household chemicals, HVAC systems, and textiles

Increased allergy testing awareness promoted by public health initiatives

Get up to 30%-40% Discount: https://www.statsandresearch.com/check-discount/40375-global-allergy-diagnostics-market

Product Type: Consumables Dominate, Instruments Evolve

Segment Analysis: By Type

The consumables segment—comprising allergen test kits, reagents, and testing plates—holds the lion’s share of market revenue. The segment's dominance is attributed to the repeat purchase nature of consumables, rising testing frequency, and the need for varied allergens detection.

In contrast, diagnostic instruments like immunoassay analyzers and microarray systems are witnessing innovation, particularly in point-of-care (POC) diagnostics, offering faster turnaround and decentralized allergy testing capabilities.

Future Outlook:

Surge in home-based diagnostic tools

Integration of AI and digital health platforms into allergy diagnostics

Strong growth in multiplex assay systems

Hospitals and Diagnostic Laboratories Are Key End-Users

Segment Analysis: By End-User

Hospital-based laboratories are currently the largest consumers of allergy diagnostic products, due to:

Greater patient volumes

Availability of specialized allergists

Comprehensive diagnostic workflows

Meanwhile, independent diagnostic labs are gaining traction, especially in developing economies, as third-party testing becomes more accessible and economically viable.

Notable Trends:

Public-private partnerships supporting allergy screenings in schools and clinics

Academic institutions leading research in novel biomarkers and allergens

Allergy Diagnostics Market Regional Insights and Growth Opportunities

North America

North America remains the global leader, driven by high healthcare expenditure, superior infrastructure, and established reimbursement pathways. The U.S. accounts for the largest share due to widespread allergy awareness, high diagnostic accuracy expectations, and well-developed insurance coverage.

Europe

Europe shows strong performance, with countries like Germany, France, and the U.K. investing in preventive care and expanding allergy screening programs. The region also benefits from:

Robust regulatory frameworks

Collaborative research hubs

High environmental consciousness

Asia-Pacific

Asia-Pacific is projected to exhibit the fastest CAGR during the forecast period. The increasing prevalence of allergies, especially in urban centers across China, India, and Southeast Asia, combined with the region's economic growth, is generating demand for scalable, cost-effective allergy diagnostics.

Competitive Landscape

Leading Allergy Diagnostics Market Players

Top companies shaping the competitive landscape include:

Thermo Fisher Scientific Inc.

Siemens Healthineers AG

Danaher Corporation

BioMérieux SA

Stallergenes Greer Ltd

Abionic SA

Omega Diagnostics Group Plc

HYCOR Biomedical

Lincoln Diagnostics Inc.

HOB Biotech Group Corp. Ltd

These companies are investing heavily in R&D, strategic acquisitions, and global distribution networks, while enhancing test accuracy and reducing turnaround time.

Key Differentiators:

Proprietary allergen panels

AI-integrated interpretation tools

Strong presence in emerging markets

Emerging Trends and Technologies

AI-Powered Diagnostics

Machine learning algorithms are increasingly being used to interpret complex allergy panels, predict cross-reactivities, and tailor personalized allergy profiles, thereby improving diagnostic precision.

Multiplex Testing

Advanced platforms capable of testing for dozens of allergens simultaneously are revolutionizing the diagnostics landscape, saving time and improving patient compliance.

Digital Integration

Remote sample collection, telemedicine integrations, and cloud-based diagnostic systems are enabling better tracking, patient management, and physician collaboration.

Regulatory and Allergy Diagnostics Market Challenges

While growth is strong, certain barriers must be addressed:

Stringent regulatory approvals delaying market entry of novel tests

Lack of uniformity in diagnostic standards across regions

Limited accessibility in rural/low-income settings

Proactive measures like global harmonization of diagnostic protocols and broader insurance coverage are necessary to maintain market momentum.

Strategic Recommendations

To outperform in this market, stakeholders should:

Invest in regional expansion, focusing on high-growth economies in Asia and Latin America

Prioritize R&D in multiplex assays and digital health integration

Establish B2B partnerships with hospitals and clinics for bundled service offerings

Educate clinicians and patients on early diagnosis and preventive testing

Develop allergen-specific panels tailored to local environmental profiles

Purchase Exclusive Report: https://www.statsandresearch.com/enquire-before/40375-global-allergy-diagnostics-market

Conclusion

The allergy diagnostics market is on an accelerated growth trajectory, driven by environmental factors, healthcare innovation, and increasing awareness. The landscape favors companies that adapt to patient-centric, technology-integrated models. As allergy prevalence climbs globally, the imperative for accurate, fast, and scalable diagnostics grows stronger. Stakeholders must act decisively to seize this window of opportunity.

Our Services:

On-Demand Reports: https://www.statsandresearch.com/on-demand-reports

Subscription Plans: https://www.statsandresearch.com/subscription-plans

Consulting Services: https://www.statsandresearch.com/consulting-services

ESG Solutions: https://www.statsandresearch.com/esg-solutions

Contact Us:

Stats and Research

Email: sales@statsandresearch.com

Phone: +91 8530698844

Website: https://www.statsandresearch.com

[jhnneelam]

Point of Care Diagnostics Market Overview 2025 and forecast till 2037

In 2024, the global Point of Care Diagnostics Market stood at an estimated USD 3.5 billion, underscoring its growing importance in the shift toward rapid and decentralized healthcare solutions. Over the forecast period from 2025 to 2037, the market is expected to maintain a steady growth trajectory, reaching nearly USD 6.1 billion by 2037, with a compound annual growth rate (CAGR) of 5.2%. This consistent growth reflects the increasing integration of decentralized diagnostic tools into primary healthcare, growing demand in resource-limited settings, and rising investment in portable medical technologies globally.

Point of Care Diagnostics Industry Demand

The Point of Care (POC) Diagnostics Market refers to the segment of medical diagnostics conducted near the site of patient care, such as in clinics, hospitals, and home settings. These diagnostics provide rapid results without the need for centralized laboratories, enabling timely clinical decisions.

The growing appeal of POC diagnostics is rooted in their cost-effectiveness, ease of use, minimal infrastructure requirements, and long shelf life. These features make them especially valuable in managing chronic conditions, detecting infectious diseases, and supporting population health in both developed and underserved regions. As healthcare systems shift towards patient-centered and value-based care, POC diagnostics are playing an increasingly vital role in early detection and monitoring.

Request Sample@ https://www.researchnester.com/sample-request-95

Point of Care Diagnostics Market: Growth Drivers & Key Restraint

Growth Drivers –

Rising Prevalence of Chronic Diseases: The growing global burden of diabetes, cardiovascular disorders, and infectious diseases like HIV, malaria, and COVID-19 continues to drive the need for POC solutions, especially in areas with limited laboratory infrastructure.

Technological Advancements and Integration of AI: Innovations such as portable molecular diagnostics, AI-driven test interpretation, and smartphone-based readers are expanding the accuracy, accessibility, and usability of POC devices.

Healthcare Decentralization and Cost-Containment Trends: The shift from hospital-centric to decentralized healthcare delivery systems, along with the demand for cost-effective diagnostic alternatives, is pushing POC diagnostics into primary care, home health, and remote monitoring environments.

Restraint –

Regulatory and Reimbursement Challenges: Regulatory hurdles and inconsistent reimbursement policies across regions can delay product approvals and limit market penetration.

Accuracy Concerns in Complex Diagnostics: Despite significant improvements, certain POC devices may lag behind centralized tests in terms of sensitivity and specificity, particularly in complex disease diagnoses.

Point of Care Diagnostics Market: Segment Analysis

Segment Analysis by Product Type –

Infectious Disease Tests: Strong demand due to continued outbreaks and endemic diseases. Respiratory and sexually transmitted infections are major testing targets.

Glucose Monitoring: A mature yet consistently growing segment fueled by the rising global diabetic population and increased adoption of home-based monitoring tools.

Cardiometabolic Tests: Rapid growth, driven by rising cardiovascular risks and the need for quick decision-making in emergency and critical care settings.

Coagulation Testing: Increasingly vital in pre-surgical assessment, anticoagulant therapy management, and stroke prevention protocols.

Pregnancy & Fertility Tests: Popular in both clinical and home settings due to convenience, privacy, and consistent consumer demand.

Segment Analysis by Platform–

Lateral Flow Assays (LFAs): Widely adopted for their simplicity and affordability, particularly in low-resource settings.

Molecular Diagnostics: Fastest-growing platform, especially for infectious diseases, driven by high sensitivity and specificity.

Immunoassays: Broadly used across multiple applications, from hormone testing to infection detection, with growing demand for multiplexing capabilities.

Microfluidics: Emerging platform with strong potential for miniaturized and automated POC systems, enhancing sample handling and throughput.

Segment Analysis by End‑User –

Hospitals: Major consumers due to demand for quick diagnostics during admissions, surgeries, and emergency care.

Clinics and Ambulatory Settings: Gaining market share as healthcare delivery moves closer to the patient.

Home Users and Others: Rising adoption of self-testing kits for chronic disease management, women’s health, and infectious disease screening is expanding this segment.

Point of Care Diagnostics Market: Regional Insights

North America:

North America remains a dominant market due to a strong healthcare infrastructure, supportive reimbursement environment, and high adoption of advanced technologies. Chronic disease burden and the expansion of retail and urgent care clinics are accelerating POC adoption in the U.S. and Canada.

Europe:

Europe shows steady growth, driven by increasing emphasis on early diagnosis, aging populations, and government support for decentralized care. Countries like Germany, the UK, and France are leading the adoption of molecular and immunoassay-based POC diagnostics.

Asia-Pacific (APAC):

APAC is the fastest-growing region, fueled by large populations, rising healthcare access, and government initiatives to combat infectious diseases. Countries like China, India, and Japan are investing heavily in both urban and rural diagnostic capabilities, making this region a key driver of future growth.

Top Players in the Point of Care Diagnostics Market

Leading companies operating in the Point of Care Diagnostics Market include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Danaher (Beckman Coulter, Cepheid), BD (Becton Dickinson), QuidelOrtho, bioMérieux, Sysmex Corporation, ARKRAY, Trinity Biotech, SD Biosensor, Thermo Fisher Scientific, Chembio Diagnostics, Eiken Chemical, PTS Diagnostics, Trividia Health, J. Mitra & Co., Boditech Med, Tulip Diagnostics, and ACON Laboratories. These players are innovating across diagnostic platforms, expanding global footprints, and forming strategic partnerships to address diverse diagnostic needs across healthcare systems.

Access Detailed Report@ https://www.researchnester.com/reports/point-of-care-poc-diagnostics-devices-market/95  

Contact for more Info:

AJ Daniel

Email: info@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

[letestmarketnews]

United States Veterinary Point of Care Diagnostics Market: Improving Animal Health Outcomes with Advanced Diagnostics

The USA Veterinary Point of Care Diagnostics market size is anticipated to exceed USD 2.28 Billion by 2033, growing at a CAGR of 9.04% from 2023 to 2033.

U.S. Veterinary Point-of-Care Diagnostics Market Accelerates

The U.S. veterinary point-of-care (POC) diagnostics market is experiencing significant growth, driven by advancements in AI-based diagnostics, real-time biosensors, and personalized pet health monitoring. Widely used in clinics, farms, and mobile units, POC tools enable rapid, on-site results. Emerging trends include telemedicine integration, wearable diagnostic devices, and a stronger focus on zoonotic disease surveillance. The market is also supported by rising pet insurance adoption and increased demand for fast infectious disease screening. Strategic partnerships, such as VolitionRx’s agreement with Heska Corporation, highlight the sector’s expansion into new markets.

This study gives a detailed analysis of drivers, restrains, opportunities and challenges limiting the market expansion of United States Veterinary Point of Care Diagnostics market. The survey included a diverse set of players, including a balance of leading and growing manufacturers for business profiling, such as;

IDEXX Zoetis Inc. Thermo Fisher Scientific Inc. Heska Corp NEOGEN Corporation Phibro Animal Health Corporation VCA, Inc. Marshfield Labs NeuroLogica Corp Blair Milling and Elevator Co., Inc. Texas A&M Veterinary Medical Diagnostic Laboratory ProtaTek International, Inc. University of Minnesota Others

Our expert team is consistently working on updated data and information on the key player's related business processes that value the market for future strategies and predictions

Get Access to a Free Copy of Our Latest Sample Report - https://www.sphericalinsights.com/request-sample/8825

Market Segmentation:

By Test Type  

Clinical Biochemistry

Immunodiagnostics

Molecular Diagnostics

Haematology

Urinalysis

Other Test Type

By Sample

Blood

Urine

Covered in this Report:

1. Go-to-market Strategy. 2. Neutral perspective on the market performance. 3. Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, QMI quadrant, and other significant analysis, as well as development status. 4. Customized regional/country reports as per request and country level analysis. 5. Potential & niche segments and regions exhibiting promising growth covered. 6.Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Buy this report now:- https://www.sphericalinsights.com/checkout/8825

Industry Developments:

In October 2023, Zomedica Corp. released a partnership in the acquisition of Qorvo Biotechnologies LLC (QBT). From this acquisition, the firm would have total access to the TRUFORMA platform, i.e., instrument, software, and multiple critical veterinary diagnostic assays created by QBT.

Benefits of the Report:

⏩ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the market. ⏩ Top-down and bottom-up approach for regional analysis ⏩ Porter’s five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players. ⏩ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Insightful inquiry before buying:- https://www.sphericalinsights.com/inquiry-before-buying/8825

Frequently asked questions:

➥ What is the market size of the United States Veterinary Point of Care Diagnostics market? ➥ What is the market growth rate of the United States Veterinary Point of Care Diagnostics market? ➥ What are the United States Veterinary Point of Care Diagnostics market opportunities and threats faced by the vendors in the United States Veterinary Point of Care Diagnostics Industry? ➥ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application? ➥ What focused approach and constraints are holding the United States Veterinary Point of Care Diagnostics market?

Unlock the full report now! @ https://www.sphericalinsights.com/reports/united-states-veterinary-point-of-care-diagnostics-market

Related Reports:

https://www.sphericalinsights.com/ko/reports/united-states-orphan-drugs-market 

https://www.sphericalinsights.com/ko/reports/north-america-business-jet-market 

https://www.sphericalinsights.com/ko/reports/france-renewable-energy-market 

https://www.sphericalinsights.com/ko/reports/italy-chocolate-market 

https://www.sphericalinsights.com/ko/reports/europe-hemostats-market 

https://www.sphericalinsights.com/ko/reports/germany-pacemakers-market 

https://www.sphericalinsights.com/ko/reports/spain-enzymes-market 

https://www.sphericalinsights.com/ko/reports/germany-peptide-antibiotics-market 

https://www.sphericalinsights.com/ko/reports/mining-geochemistry-services-market 

https://www.sphericalinsights.com/ko/reports/chemical-mechanical-polishing-market 

About the Spherical Insights

Spherical Insights is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.

Contact Us:

Company Name: Spherical Insights

Email: sales@sphericalinsights.com

Phone: +1 303 800 4326 (US)

Follow Us: LinkedIn | Facebook | Twitter

[market-insider]

AI In Oncology Market Trends and Analysis: Comprehensive Overview of Market Size, Share, Growth

The global AI in oncology market size is estimated to reach USD 19.17 billion by 2030, expanding at a CAGR of 26.17% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is anticipated to witness significant growth owing to increasing prevalence of cancer among the global population, propelling the need to develop technologically advanced products to diagnose, treat, and analyze cancer. For instance, the International Agency for Research on Cancer (IARC) expects over 20.7 million new cases in 2023. Moreover, AI enables early detection, crucial for lowering mortality, especially through efficient screening programs.

Emerging markets are witnessing a rising prevalence of cancer due to various factors, including lifestyle changes & aging populations. The surge in cancer cases in these markets creates a demand for advanced technologies like AI in oncology to improve early detection, personalized treatment, and overall patient outcomes. For instance, in January 2024, India's first AI-Precision Oncology Centre (POC) was launched at Apollo Cancer Centre in Bengaluru. The POC will utilize the vast possibilities offered by AI to help oncologists, patients, and caregivers achieve the best possible results within a specified time frame.

AI is transforming the field of oncology by integrating vast datasets from multi-omics analyses with the latest developments in deep learning and high-performance computing techniques. AI applications are expanding to include new detection, screening, diagnosis, and classification approaches, cancer genomics characterization, tumor microenvironment analysis, prognostic and predictive biomarkers assessment, and strategies for follow-up and drug discovery. For instance, in October 2022, Model Medicines launched an oncology program focusing on identifying and developing therapeutics against two epigenetic and oncogenic targets, focusing on applications for solid and hematological malignancies.

The major players operating in the market are adopting strategies such as collaborations and partnerships with a major focus on development of newer products to aid in the early diagnosis of cancer, meet rising demand, and enhance research and development pipeline. For instance, in December 2022, AstraZeneca collaborated with Clinithink to launch an AI project for lung cancer. This project aims to detect lung cancer at an early stage to aid in the developing of effective treatment.

Furthermore, in November 2022, Google Health entered into a partnership with iCAD, Inc. for the improvement of breast cancer screening using the company’s artificial intelligence technology. Additionally, a number of public and private organizations are focusing on funding and investment for R&D in AI-based oncology screening products. For instance, in March 2023, Artera received funding of USD 90 million for the launch and distribution of the ArteraAI Prostate Test, the first developed test for predicting therapy in localized prostate cancer.

For More Details or Sample Copy please visit link @: AI In Oncology Market Report

AI In Oncology Market Report Highlights

Based on component type, the software solutions segment is anticipated to grow at the fastest CAGR over the forecast period, owing to increasing adoption of software solutions for a wide number of applications due to the better outcomes offered by this component

Based on cancer type, the prostate cancer segment is anticipated to grow at the fastest CAGR over the forecast period in the market with rising prevalence amongst the population. Prostate cancer generally affects 13 out of every 100 men in the U.S., according to the data published by CDC

Based on application type, the research and development segment is expected to grow at the lucrative CAGR over the forecast period. This is attributable to the widespread adoption and amalgamation of advanced AI-enabled algorithms in pharmaceutical companies

Based on end-use, the hospitals dominated the market and registered the fastest growth owing to growing number of companies collaborating or introducing AI-powered cancer care solutions in hospitals

North America dominated the market due to the availability of favorable government initiatives and digital infrastructure to provide digital solutions to patients

[meditechinsight01]

Global Network Point-of-Care Glucose Testing Market Forecast Strong 4-5% CAGR Rise to 2029

The network point-of-care glucose testing market is projected to grow at a 4-5% CAGR during the forecast period. Primary factors include the global increase in diabetes cases, the demand for real-time monitoring solutions, the widespread adoption of digital health tools, and the rising availability of network-integrated devices. However, market growth faces limitations from high device costs and concerns around data security and patient privacy in network-connected systems.

The network point-of-care glucose testing market focuses on connectivity-enhanced solutions that allow blood sugar data to be shared across healthcare networks in real time. These devices enable rapid readings at the point of care—whether in hospitals, clinics, or home settings—allowing immediate results to be accessible to providers through electronic health records (EHRs). This connectivity supports better, faster decisions in blood sugar management, benefiting both patients and healthcare providers. By offering a streamlined approach to diabetes management, network-enabled POC glucose testing has become integral to modern patient care.

Unlock key findings! Fill out a quick inquiry to access a sample report https://meditechinsights.com/network-point-of-care-glucose-testing-market/request-sample/

Escalating Diabetes Rates: Fuel Demand for Network POC Glucose Testing

The rapid increase in diabetes prevalence worldwide has generated an urgent demand for efficient, real-time monitoring solutions, establishing network-enabled point-of-care (POC) glucose testing as a vital tool in diabetes care. Managing diabetes effectively requires frequent monitoring to prevent severe complications, and network-connected POC devices offer a transformative advantage by providing immediate readings that seamlessly integrate with electronic health records (EHRs). This instant access to glucose data allows healthcare providers to respond rapidly to changes, helping prevent blood sugar spikes or drops that could otherwise lead to serious health issues. By enabling timely interventions, network POC devices enhance patient outcomes, minimize risks, and ultimately drive greater adoption across healthcare systems.

AI Integration: A Transformational Trend in Network POC Glucose Testing

The integration of AI is redefining the network point-of-care glucose testing market, unlocking powerful predictive and personalized care capabilities. AI algorithms in these devices analyze real-time and historical data to forecast potential fluctuations, allowing healthcare providers to anticipate and proactively address sudden changes in glucose levels. These AI-driven insights go beyond simple monitoring, equipping patients with a deeper understanding of their blood sugar level patterns, which fosters more effective self-management. In healthcare settings, AI integration enables a data-rich, personalized approach to diabetes management, which not only optimizes patient care but also minimizes the risk of complications. With these advancements, AI-powered networked POC glucose testing is establishing a new benchmark for intelligent, connected medical devices, driving both innovation and increased adoption in the market.

Competitive Landscape Analysis: Network Point-Of-Care Glucose Testing Market

The global network point-of-care glucose testing market features both established and emerging players, including Abbott, LLC; Nova Biomedical; Danaher; F. Hoffmann-La Roche Ltd.; Ascensia Diabetes Care Holdings AG; Prodigy Diabetes Care, LLC; Nipro Corp. Japan; ACON Laboratories, Inc, and i-SENS, Inc. among others. Some of the key strategies adopted by market players include product innovation and development, strategic partnerships and collaborations, and geographic expansion.

Get exclusive insights - download your sample report today  https://meditechinsights.com/network-point-of-care-glucose-testing-market/request-sample/

Market Segmentation

This report by Medi-Tech Insights provides size of the network point-of-care glucose testing market at the regional- and country-level from 2022 to 2029. The report further segments the market on the basis of product and distribution channel.

Market Size & Forecast (2022-2029), By Product, USD Million

i-STAT

Accu-Chek Inform II

StatStrip

HemoCue

CareSens Expert Plus

BAROzen H Expert Plus

Market Size & Forecast (2022-2029), By Distribution Channel, USD Million

Hospitals and Clinics

Online Pharmacies

Retail Pharmacies

Others

Market Size & Forecast (2022-2029), By Region, USD Million

North America

US

Canada

Europe

UK

Germany

France

Italy

Spain

Rest of Europe

Asia Pacific

China

India

Japan

Rest of Asia Pacific

Latin America

Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde Associate, Medi-Tech Insights  +32 498 86 80 79  info@meditechinsights.com 

[dmarketblog]

How Innovation Is Reshaping the Clinical Chemistry Analyzers Market Outlook from 2024 to 2034

In the ever-evolving landscape of healthcare diagnostics, clinical chemistry analyzers have become an indispensable tool for accurate, timely, and automated lab testing. These sophisticated machines, which play a vital role in diagnosing and managing chronic and acute illnesses, are now at the forefront of innovation thanks to rising healthcare demands, advancements in technology, and the integration of artificial intelligence (AI).

As the global need for efficient and cost-effective diagnostic solutions increases, the clinical chemistry analyzers market is undergoing a significant transformation. According to recent estimates, the market is projected to reach USD 14,932.2 million in 2024 and is expected to grow at a CAGR of 4.8% through 2034, hitting a total market valuation of USD 23,825.6 million by the end of the forecast period.

Keep Up with Market Trends: Access Your Sample Report! https://www.futuremarketinsights.com/report-sample#5245502d47422d38373431

Rising Chronic Diseases: A Catalyst for Market Growth

The surge in chronic diseases such as diabetes, cardiovascular disorders, and liver diseases has created an urgent need for critical diagnostic testing. In recent years, the global pandemic underscored the importance of timely and accurate diagnoses to manage both emerging and existing health challenges. As a result, there’s a growing demand for diagnostic tools that not only deliver precise results but also streamline laboratory operations.

Enter clinical chemistry analyzers—automated machines that simplify complex testing processes. These analyzers are capable of performing a wide range of diagnostic tests such as:

Basic Metabolic Panels

Electrolyte Panels

Liver and Renal Panels

Lipid Profiles

Thyroid Function Tests

Specialty Chemical Tests

Their comprehensive capabilities make them an integral part of modern laboratories, allowing healthcare providers to quickly assess a patient’s biochemical profile and make informed decisions.

Automation and AI: Shaping the Next Era of Clinical Diagnostics

One of the most transformative trends in this space is the integration of artificial intelligence and automation technologies. As laboratories look to handle higher volumes of samples while reducing human errors and labor costs, AI-powered clinical chemistry analyzers are proving to be game-changers.

AI enables faster data interpretation, predictive maintenance, and real-time quality control, all while enhancing throughput. This technology has opened up a range of opportunities for market expansion, particularly in high-demand sectors such as diagnostic laboratories and hospitals.

Regional Insights: Asia Emerging as a Growth Powerhouse

Key Takeaways:

China is expected to register the highest growth with a CAGR of 5.7% between 2024 and 2034, highlighting its rapidly expanding market potential.

India follows closely with a CAGR of 5.0%, reflecting strong economic development and increasing demand in key sectors.

Among developed nations, Japan leads with a CAGR of 3.4%, showcasing steady market momentum.

Germany and France show solid growth prospects at 3.3% and 3.0%, respectively, driven by innovation and healthcare advancements.

Italy is projected to grow at 2.7%, slightly ahead of Canada, which has the lowest forecasted CAGR at 2.6%.

Soaring Demand for Market Information: Uncover Detailed Trends and Insights in Our Report! https://www.futuremarketinsights.com/reports/clinical-chemistry-analyzers-market

Competitive Landscape: Innovation Driving Market Dynamics

To stay ahead of the curve, leading players in the industry are investing heavily in product innovation, automation, and AI integration. They are also focusing on diversifying product portfolios to include a wider range of analyzers and reagents.

Several companies are designing compact analyzers for point-of-care (POC) settings, enabling quicker results and broadening accessibility in rural and underserved regions. Manufacturers are also working on solutions that reduce turnaround time and improve cost efficiency, aligning with the operational needs of modern labs.

Noteworthy Developments:

Beckman Coulter Diagnostics launched the DxC 500 AU Chemistry Analyzer in January 2024. This fully automated system was introduced at the Medlab Middle East conference in Dubai, and is built to optimize workflow and accuracy.

Mindray unveiled four new systems in April 2024, including two standalone analyzers (CL-2600i and BS-1000M) and two integrated solutions (M680 and M980), targeted at mid-volume laboratories looking to scale operations without incurring high labor costs.

Key Market Players

The market remains competitive with both established and emerging companies bringing innovation to the forefront. Major players include:

F. Hoffmann-La Roche Ltd.

Thermo Fisher Scientific, Inc.

Johnson & Johnson

Siemens AG

Danaher Corporation

Abbott Laboratories

HORIBA Ltd.

Sysmex Corporation

EKF Diagnostics

ELITech Group

These companies are not only advancing technology but also investing in geographic expansion and strategic collaborations to tap into emerging markets.

Segmentation: Understanding the Market Landscape

By Product:

In terms of product, the industry is segmented into analyzers, (small, medium, large, and very large), reagents, (calibrators, controls, standards, and others), and others.

By Test:

In terms of tests, the industry is bifurcated into basic metabolic panels, electrolyte panels, liver panels, lipid profiles, renal profiles, thyroid function panels, and specialty chemical tests.

By End User:

In terms of end users, the industry is segregated into hospitals, academic research centers, diagnostic laboratories, and others.

By Region:

Key countries of North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia, the Middle East, and Africa have been covered in the report.

[mordormr]

Blood Culture Tests Market: Industry Trends, Growth, and Future Prospects 

Market Overview 

The Blood Culture Tests Market size is estimated at USD 3.39 billion in 2025, and is expected to reach USD 5.03 billion by 2030, at a CAGR of 8.23% during the forecast period (2025-2030). The global blood culture tests market is experiencing substantial growth due to increasing demand for early infection detection, technological innovations, and improved healthcare infrastructure. Key market segments include: 

Conventional Blood Culture Testing 

Automated Blood Culture Systems 

Consumables (Culture Media, Assay Kits, Reagents) 

Microbial Identification Techniques (MALDI-TOF, PCR, Next-Gen Sequencing) 

Point-of-Care (PoC) Blood Culture Testing 

Key Market Drivers 

Rising Incidence of Bloodstream Infections and Sepsis: The growing prevalence of sepsis, hospital-acquired infections (HAIs), and immunocompromised patients is fueling demand for rapid blood culture testing. 

Technological Advancements in Diagnostic Systems: Automated blood culture systems with AI integration, rapid pathogen identification, and antimicrobial susceptibility testing are improving diagnostic accuracy and efficiency. 

Increased Awareness and Government Initiatives: Government programs promoting early disease detection, antimicrobial stewardship, and infection control policies are supporting market growth. 

Rising Demand for Point-of-Care (PoC) Blood Culture Testing: The shift towards portable, easy-to-use PoC diagnostic tools is enabling faster infection diagnosis, particularly in remote and resource-limited settings. 

Emerging Market Trends 

1. Growth of Automated Blood Culture Systems: Fully automated diagnostic platforms with real-time microbial detection and AI-based result interpretation are transforming the industry. 

2. Adoption of Molecular and Genomic Testing: Techniques like PCR (Polymerase Chain Reaction), MALDI-TOF mass spectrometry, and next-generation sequencing (NGS) are revolutionizing infection diagnostics. 

3. Expansion of Blood Culture Testing in Home Healthcare and Telemedicine: The rise in telehealth services and home-based testing solutions is increasing accessibility and convenience for patients. 

4. Integration of Artificial Intelligence in Blood Culture Analysis: AI-driven predictive analytics and machine learning models are enhancing accuracy, reducing false positives, and optimizing patient outcomes. 

Challenges in the Blood Culture Tests Market 

High Costs of Advanced Blood Culture Systems: Automated diagnostic equipment and molecular tests remain expensive, limiting adoption in low-income regions. 

False Positives and Contamination Issues: Errors in sample collection and handling can lead to inaccurate results, delaying proper treatment. 

Slow Turnaround Time for Conventional Culture Methods: Traditional blood culture tests take 24–72 hours for results, impacting early treatment decisions. 

Regulatory and Compliance Challenges: Stringent approval processes and regional differences in diagnostic guidelines can hinder market expansion. 

Future Outlook and Opportunities 

The blood culture tests market is set to witness rapid advancements and increased adoption with key future opportunities such as: 

Development of Ultra-Rapid Blood Culture Testing Kits for real-time infection detection. 

Expansion of AI and Big Data in Infection Diagnostics for predictive healthcare solutions. 

Increasing Adoption of Personalized Medicine and Microbiome Analysis to improve patient-specific treatments. 

Growth in Emerging Markets with improved healthcare access and investments in diagnostic technologies. 

For a detailed overview and more insights, you can refer to the full market research report by Mordor Intelligence https://www.mordorintelligence.com/industry-reports/blood-culture-tests-market 

[devotedlywingedtheorist]

Europe Point-of-Care Molecular Diagnostics Market - Global Trends, Share, Size, Growth, Opportunities and Forecast to 2028

Market Introduction

Point-of-care molecular diagnostics include portable devices, and assays & kits used to detect and diagnose diseases in human samples, such as throat swab, blood, serum, and stool. Molecular diagnostics are shifting from centralized laboratories to decentralized point-of-care molecular testing. Due to its simplicity, convenience, rapid turnaround time, and potential to improve patient outcomes, POCT is rapidly gaining traction.

Moreover, the growing demand for specific viral detection methods that consume less time for timely infection control is expected to bolster the market growth during the forecast period.

📚 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 ����𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲@ https://www.businessmarketinsights.com/sample/TIPRE00026190

In Europe, currently, the UK and Russia are the hardest-hit countries by the COVID-19 pandemic, followed by France, Spain, Italy, and Germany. The implementation of drastic measures and travel restrictions, including closing the borders, impacted the import and export of products, especially in the first half of 2020. The continuous spread of the disease has led to an elevated demand for advanced diagnostic solutions in Europe, thus boosting the adoption of point-of-care molecular diagnostic kits. Moreover, uninterrupted investments and business activities by industry players are also boosting the point-of-care molecular diagnostic market growth. In 2020, European Medicines Agency (EMA) approved ~97 medicines for the marketing authorization, of which 39 were novel drugs. In October 2020, Eurofins introduced PCR-based COVID-19 diagnostic tests with at-home, self-sampling options, in the for European market. In January 2020, European Union (EU) commission announced an emergency call, through which it awarded US$ 55.64 million to 18 research projects. Among these, 3 of the projects are receiving a total of US$ 7.39 million to develop effective, rapid point-of-care diagnostics.

📚𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐋𝐢𝐧𝐤 @ https://www.businessmarketinsights.com/reports/europe-point-of-care-molecular-diagnostics-market

𝐓𝐡𝐞 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬

bioMérieux SA

F. Hoffmann-La Roche Ltd.

Danaher Corporation

Enzo Biochem, Inc.

Abbott

binx health, Inc.

Meridian BioScience, Inc.

Biocartis

Quidel Corporation

Bio-Rad Laboratories, Inc

Segments Covered

By Product & Services

Assays and Kits

Instruments

Services and Software

By Technology

PCR

Isothermal Nucleic Acid Amplification Technology

Other Technologies

By Application

Infectious Diseases

Oncology

Hematology

Prenatal Testing

Endocrinology

Other Applications

By End User

Hospitals and Clinics

Diagnostic Laboratories

Research and Academic Institutes

Future-Oriented Perspective:

The future of POC MDx in Europe will be driven by the convergence of molecular diagnostics, digital health, and personalized medicine.

AI and machine learning will play a crucial role in enhancing diagnostic accuracy and efficiency.

Home-based testing will become increasingly prevalent, empowering individuals to take greater control of their health.

The ability to have secure, and interoperable data will be a key factor in the markets growth.

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬: Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications